home / stock / bntc / bntc news

BNTC News and Press, Benitec Biopharma Limited From 04/09/24

Stock Information
Company Name: Benitec Biopharma Limited
Stock Symbol: BNTC
Market: NASDAQ
Website: benitec.com
Menu
BNTC BNTC Quote BNTC Short BNTC News BNTC Articles BNTC Message Board
Get BNTC Alerts

News, Short Squeeze, Breakout and More Instantly...
BNTC - Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024

HAYWARD, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace...
BNTC - Benitec Biopharma files for $125M mixed securities shelf

2024-02-23 16:18:31 ET More on Benitec Seeking Alpha’s Quant Rating on Benitec Historical earnings data for Benitec Financial information for Benitec Read the full article on Seeking Alpha For further details see: Benitec Biopharma files fo...

BNTC - Benitec GAAP EPS of -$2.64

2024-02-13 09:11:23 ET More on Benitec Seeking Alpha’s Quant Rating on Benitec Historical earnings data for Benitec Financial information for Benitec Read the full article on Seeking Alpha For further details see: Benitec GAAP EPS of -$2.64

BNTC - Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update

-First Subject Dosed with BB-301 in Phase 1b/2a Clinical Treatment Study (NCT06185673) in November 2023- -Data Safety Monitoring Board Review for First Subject Completed After Day 28 Study Visit- -Second Subject Scheduled to Receive BB-301 in February 2024- -23 Subjects ...
BNTC - Expected US Company Earnings on Monday, February 12th, 2024

Verde Clean Fuels Inc. (VGAS) is expected to report for Q4 2023 Pioneer Bancorp Inc. (PBFS) is expected to report for Q2 2024 Equity Commonwealth of Beneficial Interest (EQC) is expected to report $0.27 for Q4 2023 monday.com Ltd. (MNDY) is expected to report $-0.31 for Q4 2023 As...

BNTC - Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy

HAYWARD, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace&...

BNTC - Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare Conference

HAYWARD, Calif., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed RNA interference (&...
BNTC - Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update

HAYWARD, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed RNA interference (&...

BNTC - Expected US Company Earnings on Thursday, November 9th, 2023

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

BNTC - Expected US Company Earnings on Friday, September 29th, 2023

Kalera Public Limited Company (KALRQ) is expected to report for quarter end 2023-06-30 Humanigen Inc. (HGEN) is expected to report for Q2 2023 Ever-Glory International Group Inc. (EVKG) is expected to report for quarter end 2023-06-30 SunCar Technology Group Inc. (SDA) is expected to ...
Previous 10 Next 10